Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis in Women With Recurrent Implantation Failure: A Prospective Interventional Cohort Study

NCT04528277 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT04528277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04528277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis in Women With Recurrent Implantation Failure: A Prospective Interventional Cohort Study
Lead sponsor
Huashan Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
September 1, 2020
Completion date
September 1, 2022
Enrollment
1,050 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genital tuberculoses, female, genital tuberculosis, latent, infertility, female, recurrent implantation failure